{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T17:40:28Z","timestamp":1763746828884},"reference-count":40,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2009,5,28]],"date-time":"2009-05-28T00:00:00Z","timestamp":1243468800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["J of Gastro and Hepatol"],"published-print":{"date-parts":[[2009,8]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:bold>Background and Aims:\u2002<\/jats:bold> The present study was carried out to test the hypothesis that interferon\u2010\u03b1 (IFN\u2010\u03b1) treatment would reduce or postpone the recurrence rate and improve the overall survival rate in patients after transarterial chemoembolization (TACE) treatment of hepatitis B virus (HBV) related unresectable hepatocellular carcinoma (HCC).<\/jats:p><jats:p><jats:bold>Methods:\u2002<\/jats:bold> 216 patients with unresectable HBV\u2010related HCC were randomized into a TACE group and a TACE\u2010IFN group, each group had 108 patients. In the TACE\u2010IFN group, patients received IFN\u2010\u03b11b at a dose of 3\u2003million units (mu) three times a week by intramuscular injection one week after\/before TACE treatment, for 48\u2003weeks.<\/jats:p><jats:p><jats:bold>Results:\u2002<\/jats:bold> The median disease\u2010free survival in the TACE\u2010IFN treatment group was 23.6 months (95% CI: 21.4\u201325.8) and 20.3 months (95% CI: 15.8\u201324.8) in the TACE group (<jats:italic>P<\/jats:italic>\u2003=\u20030.027). The disease free rate at 24\u2003months in the TACE group was lower than in the TACE\u2010IFN group (39.8% <jats:italic>vs<\/jats:italic> 59.3%, <jats:italic>P<\/jats:italic>\u2003=\u20030.004). The median overall survival was 29 months (95% CI: 27.5\u201332.1) in the TACE\u2010IFN group and 26 months (95% CI: 20.1\u201331.9) in the TACE group (<jats:italic>P<\/jats:italic>\u2003=\u20030.003). The 2\u2010year overall survival in the TACE\u2010IFN group was higher than in the TACE group (72.2% <jats:italic>vs<\/jats:italic> 52.8%, <jats:italic>P<\/jats:italic>\u2003=\u20030.003).<\/jats:p><jats:p><jats:bold>Conclusions:\u2002<\/jats:bold> IFN\u2010\u03b1 treatment reduced recurrence and improved the survival of patients after TACE treatment of HBV\u2010related HCC, with acceptable toxicities.<\/jats:p>","DOI":"10.1111\/j.1440-1746.2009.05863.x","type":"journal-article","created":{"date-parts":[[2009,5,28]],"date-time":"2009-05-28T07:31:31Z","timestamp":1243495891000},"page":"1437-1444","update-policy":"http:\/\/dx.doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Combination therapy with transarterial chemoembolization and interferon\u2010\u03b1 compared with transarterial chemoembolization alone for hepatitis B virus related unresectable hepatocellular carcinoma"],"prefix":"10.1111","volume":"24","author":[{"given":"Maoquan","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chenhui","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiaxing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chuanwu","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiahua","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jichong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Baoliang","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven","family":"Tucker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daoyuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,8,16]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1746.1995.tb01370.x"},{"key":"e_1_2_5_3_2","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2003.50142"},{"key":"e_1_2_5_4_2","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2002.32089"},{"key":"e_1_2_5_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)14964-1"},{"key":"e_1_2_5_6_2","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2003.50047"},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2004.09.003"},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2002.33156"},{"key":"e_1_2_5_9_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2004.09.030"},{"key":"e_1_2_5_10_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2005.04.009"},{"key":"e_1_2_5_11_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2006.05.021"},{"key":"e_1_2_5_12_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1008285123736"},{"key":"e_1_2_5_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)08649-X"},{"key":"e_1_2_5_14_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000658-199108000-00004"},{"key":"e_1_2_5_15_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19931201)72:11<3196::AID-CNCR2820721111>3.0.CO;2-Q"},{"key":"e_1_2_5_16_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19930401)71:7<2187::AID-CNCR2820710704>3.0.CO;2-J"},{"key":"e_1_2_5_17_2","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1985.156"},{"key":"e_1_2_5_18_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0142(19980301)82:5<827::AID-CNCR5>3.0.CO;2-G"},{"key":"e_1_2_5_19_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510290312"},{"key":"e_1_2_5_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(96)80022-5"},{"key":"e_1_2_5_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(95)91739-X"},{"key":"e_1_2_5_22_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-134-10-200105150-00010"},{"key":"e_1_2_5_23_2","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2000.9409"},{"key":"e_1_2_5_24_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-138-4-200302180-00008"},{"key":"e_1_2_5_25_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00687123"},{"key":"e_1_2_5_26_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.20004"},{"key":"e_1_2_5_27_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19850815)56:4<918::AID-CNCR2820560437>3.0.CO;2-E"},{"key":"e_1_2_5_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(89)91505-9"},{"key":"e_1_2_5_29_2","doi-asserted-by":"publisher","DOI":"10.1148\/radiology.197.3.7480761"},{"key":"e_1_2_5_30_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510260511"},{"key":"e_1_2_5_31_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510270617"},{"key":"e_1_2_5_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/0197-2456(90)90005-M"},{"key":"e_1_2_5_33_2","doi-asserted-by":"publisher","DOI":"10.1159\/000082092"},{"key":"e_1_2_5_34_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2893.2005.00661.x"},{"key":"e_1_2_5_35_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2004.09.045"},{"key":"e_1_2_5_36_2","first-page":"279","article-title":"Long\u2010term follow\u2010up of Japanese patients with chronic hepatitis B treated with interferon\u2010alpha","volume":"16","author":"Truong BX","year":"2005","journal-title":"Int. J. Mol. Med."},{"key":"e_1_2_5_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2004.05.014"},{"key":"e_1_2_5_38_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.0007-1323.2001.02054.x"},{"key":"e_1_2_5_39_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-006-0091-y"},{"key":"e_1_2_5_40_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.sla.0000245829.00977.45"},{"key":"e_1_2_5_41_2","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.6-1-34"}],"container-title":["Journal of Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1440-1746.2009.05863.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1440-1746.2009.05863.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T23:59:47Z","timestamp":1697327987000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1440-1746.2009.05863.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8]]},"references-count":40,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2009,8]]}},"alternative-id":["10.1111\/j.1440-1746.2009.05863.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1440-1746.2009.05863.x","archive":["Portico"],"relation":{},"ISSN":["0815-9319","1440-1746"],"issn-type":[{"value":"0815-9319","type":"print"},{"value":"1440-1746","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,8]]},"assertion":[{"value":"2009-08-16","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}